IVIEW Therapeutics is pleased to announce the appointment of Jeanette Stewart, RN, as the Director of Clinical Operations
Bringing more than 30 years of expertise in ophthalmic clinical research, Ms. Stewart is a seasoned professional who has successfully managed clinical trials across all stages of development. She is the CEO and cofounder of PRN Pharmaceutical Research Network, LLC, a leading ophthalmic clinical contract research organization (CRO), and has previously established two site management organizations (SMOs) dedicated to advancing ophthalmic studies.
Under her leadership at PRN, Ms. Stewart has effectively managed more than 70 research projects spanning the United States, Australia, Canada, and Europe. She has authored over 100 scientific articles and delivered invited lectures at major scientific meetings worldwide.
In her new role at IVIEW Therapeutics, Ms. Stewart will oversee the company’s ophthalmic clinical operations, direct trial execution across the pipeline, and continue to mentor site and project managers, clinical trial associates, and coordinators.
“Jeanette’s appointment is a recognition of her deep expertise and invaluable contributions to ophthalmic research,” said Bo Liang, Ph.D., MBA, Co-founder, Chairman, and CEO of IVIEW Therapeutics. “Her leadership in clinical operations will be instrumental as we advance our innovative therapies through clinical development.”
About IVIEW Therapeutics Inc.
IVIEW Therapeutics Inc. is a clinical-stage biotechnology company focused on developing innovative ophthalmic therapies. We invest in novel mechanisms of action and differentiated drug delivery platforms to create therapies with superior clinical profiles that address significant unmet medical needs. Our pipeline includes small molecules and gene therapies for dry eye, myopia, conjunctivitis, glaucoma, and presbyopia. The U.S. headquarters is located in Cranbury, New Jersey, with 11,045 square feet of combined laboratory and office space in the Princeton area.
For additional information, please visit www.iviewtherapeutics.com
Media Contact:
Wei Wang, PhD, Head of Operations
Email: weiwang@iviewinc.com